Cargando…

Clinical Coronary In-Stent Restenosis Follow-Up after Treatment and Analyses of Clinical Outcomes

BACKGROUND: Clinical in-stent restenosis (CISR) is the main limitation of coronary angioplasty with stent implantation. OBJECTIVE: Describe the clinical and angiographic characteristics of CISR and the outcomes over a minimum follow-up of 12 months after its diagnosis and treatment. METHODS: We anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marino, Barbara Campos Abreu, Nascimento, Guilherme Abreu, Rabelo, Walter, Marino, Marcos Antônio, Marino, Roberto Luiz, Ribeiro, Antonio Luiz Pinho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495452/ https://www.ncbi.nlm.nih.gov/pubmed/25651344 http://dx.doi.org/10.5935/abc.20140216

Ejemplares similares

Nanotechnology for the treatment of coronary in stent restenosis: a clinical perspective
por: McDowell, Garry, et al.
Publicado: (2011)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022)

Impact of text messages in a middle-income country to promote secondary prevention after acute coronary syndrome (IMPACS): A randomized trial
por: Passaglia, Luiz Guilherme, et al.
Publicado: (2019)

Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis
por: Joo, Hyung Joon, et al.
Publicado: (2018)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Heavy Coronary Calcium Mimicking In-Stent Restenosis
por: Park, Jeong-Hwan, et al.
Publicado: (2011)

In stent restenosis after percutaneous coronary intervention
por: Eyüboğlu, Mehmet
Publicado: (2016)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis
por: Demyanets, Svitlana, et al.
Publicado: (2014)

Diagnostic value of intraluminal stent enhancement in estimating coronary in-stent restenosis
por: Nogourani, Mehdi Karami, et al.
Publicado: (2020)

Coated stents to prevent restenosis in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2005)

Drug- and Gene-eluting Stents for Preventing Coronary Restenosis
por: Lekshmi, Kamali Manickavasagam, et al.
Publicado: (2017)

Treatment of coronary in-stent restenosis: a systematic review
por: Pleva, Leos, et al.
Publicado: (2018)

Diagnosis and management challenges of in-stent restenosis in coronary arteries
por: Alraies, M Chadi, et al.
Publicado: (2017)

Clinical impact and predictors of carotid artery in-stent restenosis
por: Wasser, Katrin, et al.
Publicado: (2012)

Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes
por: Jakubiak, Grzegorz K., et al.
Publicado: (2021)

In Stent Restenosis Predictors after Carotid Artery Stenting
por: Cosottini, Mirco, et al.
Publicado: (2010)

Excimer laser coronary atherectomy in double-layer stent restenosis and its evaluation with OCT
por: Vergara-Uzcategui, Carlos E, et al.
Publicado: (2023)

Differential Expression of miRNA-223 in Coronary In-Stent Restenosis
por: Ganjali, Shiva, et al.
Publicado: (2022)

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
por: Hu, Huilin, et al.
Publicado: (2021)

Intravascular imaging in coronary stent restenosis: Prevention, characterization, and management
por: Abouelnour, Amr, et al.
Publicado: (2022)

Epidemiological Profile and Quality Indicators in Patients with Acute Coronary Syndrome in Northern Minas Gerais - Minas Telecardio 2 Project
por: Marino, Bárbara Campos Abreu, et al.
Publicado: (2016)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
por: Dinesch, Violeta, et al.
Publicado: (2017)

The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention
por: Tang, Long, et al.
Publicado: (2019)

Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up
por: Cheng, Gong, et al.
Publicado: (2019)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Current Management of In-Stent Restenosis
por: Her, Ae-Young, et al.
Publicado: (2018)

Calcified in-stent restenosis in a venous stent
por: Schmidt, Jens-Ove, et al.
Publicado: (2015)

Nanoparticle Drug- and Gene-eluting Stents for the Prevention and Treatment of Coronary Restenosis
por: Yin, Rui-Xing, et al.
Publicado: (2014)

Factors Affecting In-stent Restenosis in Patients Undergoing Percutaneous Coronary Angioplasty
por: Sajadian, Mostafa, et al.
Publicado: (2018)

Coronary Angioscopy Findings before and after Excimer Laser Coronary Angioplasty for Bare-Metal Stent In-Stent Restenosis
por: Masuda, Shinichiro, et al.
Publicado: (2019)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Publicado: (2017)

Clinical characteristics of early and late drug-eluting stent in-stent restenosis and mid-term prognosis after repeated percutaneous coronary intervention
por: Zheng, Jian-Feng, et al.
Publicado: (2020)

Coronary restenosis
Publicado: (1993)

Clinical outcomes in patients treated for coronary in-stent restenosis with drug-eluting balloons: Impact of high platelet reactivity
por: Tornyos, Adrienn, et al.
Publicado: (2017)

Reduction of In-Stent Restenosis and Inflammation with One Stent: New Concept of Sirolimus and Ascorbic Acid-Eluting Coronary Stent
por: Ryu, JiWung, et al.
Publicado: (2021)

Impact of Neointimal Calcifications on Acute Stent Performance during the Treatment of In-Stent Restenosis
por: Mehanna, Emile, et al.
Publicado: (2016)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
por: Abdelmegid, Mohamed Aboel-Kassem F., et al.
Publicado: (2017)

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
por: Paramasivam, Ganesh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rc23tbt1chtg33eddvcs5rdc9p